NAD Has ‘High Hopes’ Firms Will Cooperate On Schedules To Accelerate Reviews
This article was originally published in The Rose Sheet
The National Advertising Division changes its review process to allow opposing companies greater control over scheduling and resolving their disputes. The changes, recommended by ABA committees, also impose fees on both firms in appeals and allow more time for compliance with decisions.
You may also be interested in...
The National Advertising Division is weary of companies claiming confidentiality in its dispute resolution forum without adequately detailed cause or earnest efforts to meet the option’s requirements. A panel at the group’s annual meeting discussed the issue and steps advertisers should take to protect their competitive interests without compromising themselves or the self-regulatory system.
When prompt action is a primary goal, as McNeil aimed for in challenging ad claims for Glaxo’s Flonase Allergy Relief, lawyers say going to court is a better option than going to the National Advertising Division. Even with allegations that wither under the opposing firm’s rebuttal, litigation of advertising complaints it gains publicity than a NAD review would generate.
P&G’s health care sector’s net sales grew 18% in its latest quarter. Continued growth across its sectors is critical in the face of expected $1.8bn in headwinds from commodity and freight costs in its FY2022.